ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $191,000 | -25.7% | 5,781 | -20.8% | 0.01% | -12.5% |
| Q2 2022 | $257,000 | +15.2% | 7,302 | +50.6% | 0.01% | +60.0% |
| Q1 2022 | $223,000 | -39.6% | 4,848 | -12.9% | 0.01% | -37.5% |
| Q4 2021 | $369,000 | +7.0% | 5,566 | +0.7% | 0.01% | 0.0% |
| Q3 2021 | $345,000 | -27.8% | 5,530 | -4.2% | 0.01% | -11.1% |
| Q2 2021 | $478,000 | +32.0% | 5,770 | +5.7% | 0.01% | +28.6% |
| Q1 2021 | $362,000 | -14.0% | 5,460 | -0.5% | 0.01% | -22.2% |
| Q4 2020 | $421,000 | +78.4% | 5,490 | 0.0% | 0.01% | +80.0% |
| Q3 2020 | $236,000 | -0.4% | 5,490 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $237,000 | +48.1% | 5,490 | -1.4% | 0.01% | +50.0% |
| Q1 2020 | $160,000 | -55.4% | 5,568 | -1.5% | 0.00% | -50.0% |
| Q4 2019 | $359,000 | +120.2% | 5,653 | -2.4% | 0.01% | +100.0% |
| Q3 2019 | $163,000 | +5.2% | 5,793 | -0.9% | 0.00% | +33.3% |
| Q2 2019 | $155,000 | -71.4% | 5,843 | -92.1% | 0.00% | -72.7% |
| Q3 2016 | $542,000 | – | 73,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |